scholarly article | Q13442814 |
P2093 | author name string | Benjamin A. Lipsky | |
Warren S. Joseph | |||
P2860 | cites work | Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. | Q34097990 |
Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate | Q34284305 | ||
Diagnosis and treatment of diabetic foot infections | Q34357233 | ||
Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation | Q34468265 | ||
A report from the international consensus on diagnosing and treating the infected diabetic foot | Q35777058 | ||
Optimising antimicrobial therapy in diabetic foot infections | Q36729589 | ||
Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. | Q37149371 | ||
MRSA and diabetic foot wounds: contaminating or infecting organisms? | Q37642930 | ||
Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics | Q37679501 | ||
Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot | Q43264748 | ||
Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem | Q44311731 | ||
Extended spectrum beta lactamase (ESBL) producing Escherichia coli and klebsiella pneumoniae in diabetic foot infection. | Q54418389 | ||
Investigating suspected bone infection in the diabetic foot | Q57543674 | ||
Validation of the Infectious Diseases Society of America's Diabetic Foot Infection Classification System | Q57543736 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 395-400 | |
P577 | publication date | 2010-09-01 | |
P1433 | published in | Journal of the American Podiatric Medical Association | Q15750487 |
P1476 | title | Medical therapy of diabetic foot infections | |
Medical Therapy of Diabetic Foot Infections | |||
P478 | volume | 100 |
Q36592698 | Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study | cites work | P2860 |